TerrAscend announced that its greenhouse located at its Boonton facility has been approved by the New Jersey Department of Health to begin cultivating cannabis. Concurrently, TerrAscend has commenced initial planting of this facility with the first harvest anticipated to occur during the fourth quarter of this year.
Through a newly signed agreement, Precision, a Detroit-based company with an extensive portfolio of cannabis extraction, refinement, and processing technologies, will provide state-of-the-art equipment for TerrAscend’s current and future product lines.
TerrAscend Corp., a leading North American cannabis operator, today announced it will open its award-winning Apothecarium branded dispensaries in two Pennsylvania locations; one in Lancaster and a second in Plymouth Meeting.
This research evaluates thousands of subjects who are current or past participants in the New Jersey Medical Marijuana Program who were asked to answer a variety of questions based on their first-hand experience.
Medical cannabis healthcare network and collaborators are pleased to announce the conclusion and publication of a medical marijuana focused observational study in Pennsylvania.
Micro-dosing is defined as the administration of doses so low that they are unlikely to produce a whole-body effect, but high enough to allow a cellular response.